SIM
ARRY

Spark Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Spark Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-343,900
Closed -$3.07M – 924
2017
Q1 		$3.07M Buy
343,900
+81,200
+31% +$864K 0.19% 165
2016
Q4 		$2.31M Sell
262,700
-615,100
-70% -$4.53M 0.19% 169
2016
Q3 		$5.92M Buy
877,800
+495,600
+130% +$1.92M 0.48% 38
2016
Q2 		$1.36M Sell
382,200
-168,700
-31% -$550K 0.13% 258
2016
Q1 		$1.63M Buy
550,900
+529,000
+2,416% +$1.58M 0.16% 200
2015
Q4 		$92K Sell
21,900
-227,300
-91% -$1.04M 0.01% 670
2015
Q3 		$1.13M Buy
249,200
+180,200
+261% +$1.07M 0.15% 228
2015
Q2 		$496K Buy
+69,000
New +$509K 0.07% 359

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Spark Investment Management's ARRY Position: Q2 2017 in Review

Spark Investment Management sold out of Array Biopharma Inc (ARRY) in Q2 2017, closing a stake of 343,900 shares — an estimated $3.07M sold.

Spark Investment Management first reported a position in ARRY in Q2 2015 and held it in 8 quarters. The position peaked at $5.92M in Q3 2016. 182 funds tracked by Wall St. Rank hold ARRY as of Q2 2017.

  • Spark Investment Management reported no remaining Array Biopharma Inc position as of Q2 2017 after selling out during the quarter.
  • Spark Investment Management sold 343,900 Array Biopharma Inc shares in Q2 2017, an estimated $3.07M.
  • Spark Investment Management first reported a position in Array Biopharma Inc in Q2 2015 and held it in 8 quarters.
  • Spark Investment Management's Array Biopharma Inc position peaked at $5.92M in Q3 2016.
  • 182 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2017.

Based on Spark Investment Management's 13F filing for Q2 2017, filed 27 Jul 2017.